210 related articles for article (PubMed ID: 30888867)
1. Effect of Background Parenchymal Enhancement on Cancer Risk Across Different High-Risk Patient Populations Undergoing Screening Breast MRI.
Sippo DA; Rutledge GM; Burk KS; Mercaldo SF; Dontchos BN; Edmonds CE; Lehman CD
AJR Am J Roentgenol; 2019 Mar; 212(6):1412-1418. PubMed ID: 30888867
[TBL] [Abstract][Full Text] [Related]
2. Population-Based Assessment of the Association Between Magnetic Resonance Imaging Background Parenchymal Enhancement and Future Primary Breast Cancer Risk.
Arasu VA; Miglioretti DL; Sprague BL; Alsheik NH; Buist DSM; Henderson LM; Herschorn SD; Lee JM; Onega T; Rauscher GH; Wernli KJ; Lehman CD; Kerlikowske K
J Clin Oncol; 2019 Apr; 37(12):954-963. PubMed ID: 30625040
[TBL] [Abstract][Full Text] [Related]
3. Relationship between Background Parenchymal Enhancement on High-risk Screening MRI and Future Breast Cancer Risk.
Grimm LJ; Saha A; Ghate SV; Kim C; Soo MS; Yoon SC; Mazurowski MA
Acad Radiol; 2019 Jan; 26(1):69-75. PubMed ID: 29602724
[TBL] [Abstract][Full Text] [Related]
4. Association of breast cancer with MRI background parenchymal enhancement: the IMAGINE case-control study.
Watt GP; Sung J; Morris EA; Buys SS; Bradbury AR; Brooks JD; Conant EF; Weinstein SP; Kontos D; Woods M; Colonna SV; Liang X; Stein MA; Pike MC; Bernstein JL
Breast Cancer Res; 2020 Dec; 22(1):138. PubMed ID: 33287857
[TBL] [Abstract][Full Text] [Related]
5. Impact of Background Parenchymal Enhancement on Diagnostic Performance in Screening Breast MRI.
Sippo DA; Rutledge GM; Mercaldo SF; Burk KS; Edmonds CE; Dang PA; Lehman CD
Acad Radiol; 2020 May; 27(5):663-671. PubMed ID: 31327575
[TBL] [Abstract][Full Text] [Related]
6. Are Qualitative Assessments of Background Parenchymal Enhancement, Amount of Fibroglandular Tissue on MR Images, and Mammographic Density Associated with Breast Cancer Risk?
Dontchos BN; Rahbar H; Partridge SC; Korde LA; Lam DL; Scheel JR; Peacock S; Lehman CD
Radiology; 2015 Aug; 276(2):371-80. PubMed ID: 25965809
[TBL] [Abstract][Full Text] [Related]
7. Automated rating of background parenchymal enhancement in MRI of extremely dense breasts without compromising the association with breast cancer in the DENSE trial.
Wang H; H M van der Velden B; Verburg E; Bakker MF; Pijnappel RM; Veldhuis WB; van Gils CH; Gilhuijs KGA
Eur J Radiol; 2024 Jun; 175():111442. PubMed ID: 38583349
[TBL] [Abstract][Full Text] [Related]
8. Repeated surgeries in invasive lobular breast cancer with preoperative MRI: Role of additional carcinoma in situ and background parenchymal enhancement.
Preibsch H; Richter V; Bahrs SD; Hattermann V; Wietek BM; Bier G; Kloth C; Blumenstock G; Hahn M; Staebler A; Nikolaou K; Wiesinger B
Eur J Radiol; 2017 May; 90():181-187. PubMed ID: 28583631
[TBL] [Abstract][Full Text] [Related]
9. Breast Background Parenchymal Enhancement on Screening Magnetic Resonance Imaging in Women Who Received Chest Radiotherapy for Childhood Hodgkin's Lymphoma.
Zeng L; Lo G; Moshonov H; Liang J; Hodgson D; Crystal P
Acad Radiol; 2016 Feb; 23(2):168-75. PubMed ID: 26546383
[TBL] [Abstract][Full Text] [Related]
10. Foci on breast magnetic resonance imaging in high-risk women: cancer or not?
Clauser P; Cassano E; De Nicolò A; Rotili A; Bonanni B; Bazzocchi M; Zuiani C
Radiol Med; 2016 Aug; 121(8):611-7. PubMed ID: 27169908
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Background Parenchymal Enhancement at Contrast-enhanced Spectral Mammography and Breast MR Imaging.
Sogani J; Morris EA; Kaplan JB; D'Alessio D; Goldman D; Moskowitz CS; Jochelson MS
Radiology; 2017 Jan; 282(1):63-73. PubMed ID: 27379544
[TBL] [Abstract][Full Text] [Related]
12. Performance of Screening Breast MRI across Women with Different Elevated Breast Cancer Risk Indications.
Sippo DA; Burk KS; Mercaldo SF; Rutledge GM; Edmonds C; Guan Z; Hughes KS; Lehman CD
Radiology; 2019 Jul; 292(1):51-59. PubMed ID: 31063080
[TBL] [Abstract][Full Text] [Related]
13. The Association of Background Parenchymal Enhancement at Breast MRI with Breast Cancer: A Systematic Review and Meta-Analysis.
Thompson CM; Mallawaarachchi I; Dwivedi DK; Ayyappan AP; Shokar NK; Lakshmanaswamy R; Dwivedi AK
Radiology; 2019 Sep; 292(3):552-561. PubMed ID: 31237494
[TBL] [Abstract][Full Text] [Related]
14. Breast MRI background parenchymal enhancement as an imaging bridge to molecular cancer sub-type.
Dilorenzo G; Telegrafo M; La Forgia D; Stabile Ianora AA; Moschetta M
Eur J Radiol; 2019 Apr; 113():148-152. PubMed ID: 30927939
[TBL] [Abstract][Full Text] [Related]
15. Background parenchymal enhancement at breast MR imaging and breast cancer risk.
King V; Brooks JD; Bernstein JL; Reiner AS; Pike MC; Morris EA
Radiology; 2011 Jul; 260(1):50-60. PubMed ID: 21493794
[TBL] [Abstract][Full Text] [Related]
16. Effect of Background Parenchymal Enhancement on Breast MR Imaging Interpretive Performance in Community-based Practices.
Ray KM; Kerlikowske K; Lobach IV; Hofmann MB; Greenwood HI; Arasu VA; Hylton NM; Joe BN
Radiology; 2018 Mar; 286(3):822-829. PubMed ID: 29072981
[TBL] [Abstract][Full Text] [Related]
17. MRI Background Parenchymal Enhancement Is Not Associated with Breast Cancer.
Bennani-Baiti B; Dietzel M; Baltzer PA
PLoS One; 2016; 11(7):e0158573. PubMed ID: 27379395
[TBL] [Abstract][Full Text] [Related]
18. The correlation of background parenchymal enhancement in the contralateral breast with patient and tumor characteristics of MRI-screen detected breast cancers.
Vreemann S; Gubern-Mérida A; Borelli C; Bult P; Karssemeijer N; Mann RM
PLoS One; 2018; 13(1):e0191399. PubMed ID: 29351560
[TBL] [Abstract][Full Text] [Related]
19. Factors Associated With Background Parenchymal Enhancement on Contrast-Enhanced Mammography.
Karimi Z; Phillips J; Slanetz P; Lotfi P; Dialani V; Karimova J; Mehta T
AJR Am J Roentgenol; 2021 Feb; 216(2):340-348. PubMed ID: 32755162
[No Abstract] [Full Text] [Related]
20. Breast MRI contrast enhancement kinetics of normal parenchyma correlate with presence of breast cancer.
Wu S; Berg WA; Zuley ML; Kurland BF; Jankowitz RC; Nishikawa R; Gur D; Sumkin JH
Breast Cancer Res; 2016 Jul; 18(1):76. PubMed ID: 27449059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]